Featured Publications

Labor, Employment and Benefits: Alert - February 6, 2012

The U.S. Supreme Court recently denied an employer’s request for review of a decision by the U.S. Court of Appeals for the Eighth Circuit, which held that tipped employees spending more than 20 percent of their time performing related but non-tipped duties must be paid the full minimum wage for that time, without the tip credit.

More

Construction: Alert - January 30, 2012

For almost 50 years, lessors have had the ability to limit their liability for liens that arose from improvements to the leasehold made by a lessee. However, in the most recent legislative session, the Florida Legislature enacted revisions to Florida Statute § 713.10 that provide a potential pitfall for lessors by inserting a provision that may allow a contractor to lien the lessor's interest even where there is a recorded document advising of the limitation of liens.

More

Search Our Library

Search

  • Printer friendly
  • Email this page to a friend
  • Generate a PDF version of this page

Press Releases

Michael Werner Joins Holland & Knight as Partner in the Public Policy Group in Washington, D.C.
 
 April 13, 2009
 
Michael J. Werner- Washington

WASHINGTON – Holland & Knight announced today that Michael Werner has joined the firm's Washington, D.C. office as a partner in the Public Policy & Regulation Practice Group, with a focus on healthcare.

Werner is an expert in legislative, regulatory, and bioethics matters regarding health care delivery, life sciences and medical research. He specifically focuses on issues related to clinical trials and research, drug and biologics development, comparative effectiveness, PDUFA, as well as stem cell research and regenerative medicine. Werner has extensive experience lobbying Congress, negotiating with federal agencies, as well as executing and developing programs, public awareness campaigns, and business operations.

"We are delighted to welcome Michael to Holland & Knight. His vast experience with bioethics and understanding of drug development will assist us in strengthening our healthcare practice and ability to best serve our clients' needs," said Michael Gaba, partner and Federal Policy leader of the firm’s national Health Law and Life Sciences Team.

Werner has published numerous articles in a variety of publications and speaks frequently on issues such as stem cell research, FDA and drug approval and the business of science.

Prior to joining Holland & Knight, Werner was the president of The Werner Group, a bioethics consulting firm. Werner received his B.A., with distinction, from the University of Michigan, and his J.D. from The George Washington University.

Related Practices